Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03569319
Other study ID # 18/NI/0077
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 18, 2018
Est. completion date June 30, 2019

Study information

Verified date April 2024
Source Queen's University, Belfast
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It is estimated that 30% of Alzheimer's disease cases globally are associated with changeable risk factors, such as diet and physical activity. In particular, a Mediterranean diet (MD) has been associated with reduced risk of cognitive decline and improved brain function. The investigators developed educational resources on the Mediterranean diet and lifestyle (THINK-MED) in accordance with the Medical Research Council guidance for developing and evaluating complex interventions, based on a systematic literature review and informed by qualitative work with patients with mild memory problems.The feedback gathered informed refinements and tailoring of the resource and overall MD intervention. This study aims to evaluate feasibility of the "THINK-MED" Mediterranean lifestyle educational intervention to encourage dietary behaviour change among community-dwelling people with subjective cognitive impairment.


Description:

This pilot RCT aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention (THINK-MED) to encourage behaviour change among participants who have subjective cognitive impairment. This study will be a 6 month randomised controlled trial (RCT) with a total of 30 participants who will be randomised to 1 of 3 groups: 1. Group 1 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource on one occasion at baseline (n=10) 2. Group 2 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource at monthly intervals for 5 months, with an initial face-to-face visit from the research dietitian (month 1) and accompanied by telephone feedback (month 2-5) (n=10) 3. Group 3 is a control group. Participants in this group will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource after completing the 6 month study (n=10)


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date June 30, 2019
Est. primary completion date June 30, 2019
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Have subjective cognitive impairment - Montreal Cognitive Assessment (MoCA) score = 26/30 - Mediterranean diet score (MDS) = 4 (Estruch et al. 2006) - Willing to make changes to their diet Exclusion Criteria: - Diagnosis of dementia - MoCA score of = 25/30 - Individuals with a visual or English language impairment - Psychiatric problems e.g. depression - Significant medical comorbidity - Body Mass Index (BMI) = 19 and = 40 kg/m2 - Excessive alcohol consumption - Dietary restrictions/allergies that would substantially limit ability to complete study requirements - Inability to provide informed consent - History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
"THINK-MED" resource (baseline)
The "THINK-MED" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards. Participants will receive this resource on one occasion at baseline.
"THINK-MED" resource (staged)
This group of participants will receive the "THINK-MED" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
Control
Participants will receive the "THINK-MED" resource after their final 6 month study visit (i.e. delayed intervention).

Locations

Country Name City State
United Kingdom Queen's University Belfast

Sponsors (2)

Lead Sponsor Collaborator
Queen's University, Belfast Wellcome Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Process Evaluation (1) - telephone contact evaluation Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation Up to 3 months post intervention
Other Process Evaluation (2) - study records A review of study records- including attrition rates, reason for dropout Up to 3 months post intervention
Other Process Evaluation (3) - structured interviews Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials Up to 3 months post intervention
Primary Change in Mediterranean Diet Score (MDS) at 6 months Mediterranean dietary intake will be measured by a validated questionnaire with a increase in score by greater than or equal to 3 points at 6 months indicating adoption (maximum score 14) Baseline, 6 months
Secondary Change in Physical Activity at 6 months Physical activity will be measured by the Recent Physical Activity Questionnaire (RPAQ) Baseline, 6 months
Secondary Anthropometric measurements Weight and height measurements to calculate BMI Baseline, 6 months
Secondary Muscle Strength Measured using a grip-strength dynamometer Baseline, 6 months
Secondary Geriatric Depression Scale Depressive symptoms will be measured by the Geriatric Depression Scale Questionnaire, with a score greater than 5 indicating depressive symptoms Baseline, 6 months
Secondary Functional Assessment (1) Measured by the instrumental activities of daily living questionnaire (IADL) by Lawton and Brody Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire Baseline, 6 months
Secondary Functional Assessment (2) Measured by the Bristol activities of daily living (Bucks et al. 1996) questionnaire Baseline, 6 months
Secondary Cognitive Assessment A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.) Baseline, 6 months
Secondary 4 day food diary A food diary will be completed to assess compliance with a Mediterranean diet Baseline, 6 months
Secondary Change in Lifestyle questionnaire A questionnaire to measure change in lifestyle behaviours Baseline, 6 months
Secondary Dietary Quality of Life questionnaire A questionnaire to measure dietary quality of life Baseline, 6 months
Secondary Mediterranean Diet Knowledge questionnaire A questionnaire to measure participants Mediterranean diet knowledge Baseline, 6 months
Secondary Rand Short Form-36 HEALTH SURVEY A questionnaire to measure participants views and beliefs on health Baseline, 6 months
Secondary Staging Algorithm Questionnaire A questionnaire to measure participants readiness to change their diet and lifestyle Baseline, 6 months
Secondary Mediterranean Diet self-efficacy questionnaire A questionnaire to measure participants self-efficacy Baseline, 6 months
Secondary Barriers to consuming a Mediterranean Diet questionnaire Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet Baseline, 6 months
Secondary Blood Sample A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk. Baseline, 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Not yet recruiting NCT05485025 - Long Term Prospective Study of Tai Chi Intervention to Delay the Progression of Subjective Cognitive Impairment N/A
Recruiting NCT05534607 - Natives Engaged in Alzheimers Research - 'Ike Kupuna N/A
Recruiting NCT03650816 - Cerebrovascular Reactivity in Alzheimer's Disease
Completed NCT01261741 - Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems Phase 2
Completed NCT05167045 - A Pilot Study for the Brain Health Support Program
Recruiting NCT06089096 - Sleep Apnea and Cognitive Function in Subjects With Subjective or Mild Cognitive Impairment
Recruiting NCT06005038 - CogT pSOPT Intervention Study Phase 1
Recruiting NCT03330470 - Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease N/A
Recruiting NCT03020381 - Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
Recruiting NCT05893524 - Uppsala-Dalarna Dementia and Gait Project
Active, not recruiting NCT05347966 - Brain Health Support Program N/A
Recruiting NCT06058611 - Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities N/A